MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.pupt.2021.101999

Медицинская библиотека · Pulmonary pharmacology & therapeutics · 2021

Risk factors associated with increased discontinuation rate of trimethoprim-sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort study.

Otani Toshihito, Yamaguchi Kakuhiro, Sakamoto Shinjiro, Horimasu Yasushi, Masuda Takeshi, Miyamoto Shintaro, Nakashima Taku, Iwamoto Hiroshi, Hirata Shintaro, Fujitaka Kazunori, Hamada Hironobu, Sugiyama Eiji, Hattori Noboru

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The use of trimethoprim-sulfamethoxazole (TMP-SMX) for Pneumocystis pneumonia (PcP) prophylaxis is often discontinued owing to adverse drug reactions. Half-dosage of TMP-SMX (40/200 mg daily) is considered more tolerable than the conventional dosage (80/400 mg daily). However, patient background characteristics that are associated with the discontinuation of TMP-SMX prophylaxis and suitable for reduced dosage remain unclear. In this study, we aimed to identify the risk factors for the discontinuation of and efficacy of different doses of TMP-SMX prophylaxis in patients with creatinine clearance higher than 30 mL/min.

METHODS

We retrospectively evaluated 318 immunocompromised non-human immunodeficiency virus (HIV)-infected patients (194 men and 124 women; median age, 68.5 [interquartile range, 59-75] years) who underwent TMP-SMX therapy as a primary PcP prophylaxis between July 2014 and August 2019. The patients were segregated into two groups on the basis of dosage: single-strength (SS; n = 244) and half-strength (HS; n = 74) groups. We evaluated PcP occurrence, TMP-SMX discontinuation rate, and discontinuation-related risk factors in these groups.

RESULTS

PcP did not occur in either group. The univariate and multivariate Cox proportional hazards models revealed that the SS dosage and renal function (e.g. serum creatinine and creatinine clearance) were independently associated with prophylaxis discontinuation. At 24 weeks, the HS group presented significantly lower discontinuation rates than the SS group (P = 0.019, log-rank test). In the SS group, patients with mild renal impairment (e.g. serum creatinine ≥0.78 mg/dL or creatinine clearance ≤64.26 mL/min) presented significantly higher TMP-SMX discontinuation rates than those without such an impairment (P < 0.05, log-rank test with Bonferroni correction). This difference was not significant in the HS group.

CONCLUSION

Mild renal impairment might increase the risk of discontinuation of conventional TMP-SMX prophylaxis. In patients with a mild renal impairment, the HS dosage may improve tolerability while maintaining prophylactic efficacy.

Для цитирования: Otani Toshihito, Yamaguchi Kakuhiro, Sakamoto Shinjiro, Horimasu Yasushi, Masuda Takeshi, Miyamoto Shintaro, Nakashima Taku, Iwamoto Hiroshi, Hirata Shintaro, Fujitaka Kazunori, Hamada Hironobu, Sugiyama Eiji, Hattori Noboru. Risk factors associated with increased discontinuation rate of trimethoprim-sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort study.. Pulmonary pharmacology & therapeutics. 2021. DOI: 10.1016/j.pupt.2021.101999.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.